TIM
BMY.RT

Thompson Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Thompson Investment Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80,999
Closed -$56K – 203
2020
Q4 		$56K Sell
80,999
-1,172
-1% -$2.5K 0.01% 187
2020
Q3 		$185K Sell
82,171
-1,415
-2% -$4.04K 0.03% 182
2020
Q2 		$299K Sell
83,586
-1,891
-2% -$6.82K 0.06% 153
2020
Q1 		$325K Sell
85,477
-875
-1% -$2.88K 0.07% 139
2019
Q4 		$260K Buy
+86,352
New +$225K 0.04% 167

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Thompson Investment Management's BMY.RT Position: Q1 2021 in Review

Thompson Investment Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 80,999 shares — an estimated $56K sold.

Thompson Investment Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $325K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Thompson Investment Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Thompson Investment Management sold 80,999 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $56K.
  • Thompson Investment Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Thompson Investment Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $325K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Thompson Investment Management's 13F filing for Q1 2021, filed 7 Apr 2021.